136
SCIENTIFIC PROGRAMME
| Programme and Exhibition Guide
MONDAY 8 MAY 2017
SYMPOSIUMWITH PROFFERED PAPERS
Novel approaches in prostate tumour control
10:30 - 11:30 | LEHAR 4
This symposium on prostate cancer will shed light on several fundamental
characteristics similarly important in other tumour types. The presenters will discuss
intra- and inter-patient heterogeneity in terms of clinical response and genetics,
define the genetics of aggressive localised sporadic prostate cancer with particular
focus on BRCA2 mutated prostate cancers and other genes of DNA damage response
and DNA repair pathways in localised and metastatic prostate cancer, outline how
the tumour microenvironment impacts on prognosis and prostate cancer genetics,
and, finally, discuss the status and the development of novel prognostic and
predictive factors for prostate cancer precision medicine.
Chair: N. Cordes (Germany)
Co-chair: G. Goldner (Austria)
10:30 > State of the art in prostate tumour radiobiology
C. Peitzsch (Germany)
SP-0434
10:55 > Novel developments in molecular targeting of prostate cancer
R. Bristow (Canada)
SP-0435
11:20 > Cytokine-dependent regulation of prostate cancer stem cell
maintenance in response to irradiation
C. Peitzsch (Germany), M. Baumbach, M. Cojoc, L. Hein, I. Kurth,
M. Baumann, M. Krause, A. Dubrovska
OC-0436
PROFFERED PAPERS
New technologies for imaging and therapy
10:30 - 11:30 | STRAUS 2-3
Chair: T. Knöös (Sweden)
Chair: M.d.C. Lopes (Portugal)
10:30 > Scatter imaging: promising modality for image guided ablation
radiotherapy for lung cancer patients
J. Chu (USA), G. Redler, G. Cifter, K. Jones, J. Turian
OC-0437
10:40 > The impact of a 1.5 T MR-Linac fringe field on neighbouring linear
accelerators.
T. Perik (The Netherlands), J. Kaas, F. Wittkamper
OC-0438
10:50 > Treating patients with Dynamic Wave Arc: first clinical experience
M. Burghelea (Belgium), D. Verellen, J. Dhont, C. Hung, K. Poels,
R. Van den Begin, M. Boussaer, K. Tournel, C. Jaudet, T. Reynders,
T. Gevaert, V. Simon, M. De Ridder
OC-0439